Jennifer (Jen) Pardi, MBA was appointed Global Head of Equity Capital Markets in October 2020 and is responsible for oversight of Canaccord Genuity’s global ECM activities, with a focus on driving coordination and best practices across all regions to drive optimal outcomes for our corporate and institutional clients.
Jen joined Adams Harkness (acquired by Canaccord in 2005) in 2003. She has held roles of increasing responsibility within the U.S. ECM team and has been integral to increasing CG’s U.S. syndicate participation and subsequent advancement to a top-ranked midmarket investment dealer in the region. She was promoted to Head of U.S. Equity Capital Markets in September 2013. With extensive corporate finance, equity and debt capital markets experience, Jen has been at the forefront of Canaccord Genuity’s cross-border equity capital markets activities and has been involved in the completion of over 1,000 transactions with an aggregate value of over $150 billion.
Based in Boston, Jen also serves on Canaccord Genuity’s U.S. Operating Committee. She has been a significant contributor to CG’s firmwide diversity initiatives, with a strong focus on increasing opportunities for women entering the capital markets, in addition to driving CG’s participation in various local community and charitable initiatives.
Selected Transactions
-
$217m
PLBY Group
Joint Bookrunner
-
US$69m
Exagen Inc.
Bookrunner (Follow-on)
-
US$60m
RADA Electronic Industries LTD.
Joint Bookrunner (Follow-on)
-
US$175m
Travere Therapeutics Inc.
Lead Manager (Follow-on)
-
US$69m
Kaledio
Lead Manager (Follow-On)
-
US$173m
Rhythm Pharmaceuticals, Inc.
Lead Manager (Follow-On)
-
US$138m
Adicet Bio, Inc.
Co-Manager (CMPO)
-
US$50m
VSE Corporation
Lead Manager (Follow-on)
-
US$288m
Silvergate Capital Corporation
Joint Bookrunner (Follow-on)